中大醫學院胸腔外科團隊完成【全球最多BMA成功個案】
【全球最多BMA成功個案】中大醫學院胸腔外科團隊完成全球最多宗混合手術室「經氣管微波消融術」（BMA）個案，是無創治療肺癌的一個里程碑。團隊由外科學系心胸外科組吳士衡教授領導，於2019年3月順利完成亞太區首宗BMA。截至今年6月13日，團隊更完成71宗相關個案。病人在手術期間並無出血，超過八成個案術後亦無痛楚，可於翌日出院，較一般微創手術需留醫3至5天縮短。
BMA是在擁有最先進電腦掃瞄和成像設備的混合手術室進行，醫生在電磁導航下放置支氣管鏡，再將用作消融的導管探頭準確放到肺癌組織位置，導管會釋放微波能量，破壞肺癌組織。吳教授表示：「我們的經驗顯示BMA是一種安全、可行及有效的治療，日後可成為某類病人早期肺癌的主要治療模式。配合電磁導航支氣管鏡下的活檢，加上術中的病理分析，在混合手術室進行的BMA有望為有可疑肺結節的病人，提供一站式診斷和治療。」
這項新治療方案適用於手術風險較高，或曾拒絕接受手術和放射治療的肺癌病人。肺癌組織的體積較細，兼位於肺部較外圍，都有助BMA治療達到較好效果。
詳情: https://bit.ly/3cs6cNi
【Largest number of successful BMA cases】Thoracic surgical team of CU Medicine has become the most experienced team worldwide in performing non-invasive Bronchoscopic Microwave Ablation (BMA) in hybrid operating room for lung cancer treatment.
The team, led by Professor Calvin NG from the Division of Cardiothoracic Surgery at the Department of Surgery, performed the Asia-Pacific’s first BMA case in March of 2019. As of 13 June 2021, 71 BMA cases have been successfully performed by the team. The operation results in no blood loss and over 80% of cases reported no post-procedural pain. The majority of BMA cases were discharged on the following day which is much quicker than conventional treatment by minimally invasive surgery that entails hospital stay of 3 to 5 days.
BMA is performed in a hybrid operating room with state of the art CT scan and imaging facilities. Through the use of electromagnetic navigation bronchoscopy (ENB), surgeons precisely deploy an antenna for ablation into the lung cancer and thermally destroy the diseased tissue by the emitted microwave energy.
Professor Ng stated, “Our experience shows that BMA is safe, feasible and effective. This represents an important future treatment modality for early stage lung cancers in select patients. Together with ENB biopsy and intra-operative pathological evaluation, BMA in the hybrid operating room is capable of providing a one-stop diagnosis and treatment for suspicious lung nodules.”
This novel approach to lung cancer treatment can be offered to patients with high surgical risks or have declined surgery and radiotherapy. Smaller lung tumours and those located at the periphery are favourable radiologic features for BMA.
More details: https://bit.ly/3cs6cNi
文章來自:中文大學醫學院
